Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(12):811; doi:10.1093/jnci/djj273
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

Awards, Appointments, Announcements

The first 10% of the full text of this article appears below.

{blacksquare} Paul Seligman, M.D., was appointed associate center director for safety policy and communication in the Center for Drug Evaluation and Research at the FDA. Seligman joined the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?